E. Myrsky

发表

Altered small-bowel mucosal vascular network in untreated coeliac disease

K. Kaukinen, I. Korponay-Szabó, M. Mäki, 2009, Scandinavian journal of gastroenterology.

Celiac disease IgA modulates vascular permeability in vitro through the activity of transglutaminase 2 and RhoA

K. Kaukinen, I. Korponay-Szabó, M. Mäki, 2009, Cellular and Molecular Life Sciences.

Erratum to: RhoB is associated with the anti-angiogenic effects of celiac patient transglutaminase 2-targeted autoantibodies

K. Kaukinen, I. Korponay-Szabó, M. Mäki, 2012, Journal of Molecular Medicine.

Membrane potential and endocytic activity control disintegration of cell–cell adhesion and cell fusion in vinculin‐injected MDBK cells

S. Eskelinen, R. Palovuori, E. Myrsky, 2004, Journal of cellular physiology.

Coeliac disease‐specific autoantibodies targeted against transglutaminase 2 disturb angiogenesis

K. Kaukinen, I. Korponay-Szabó, M. Mäki, 2008, Clinical and experimental immunology.

RhoB is associated with the anti-angiogenic effects of celiac patient transglutaminase 2-targeted autoantibodies

K. Kaukinen, I. Korponay-Szabó, M. Mäki, 2012, Journal of Molecular Medicine.

Epithelial transport and deamidation of gliadin peptides: a role for coeliac disease patient immunoglobulin A

K. Kaukinen, I. Korponay-Szabó, M. Mäki, 2011, Clinical and experimental immunology.

Inhibition of transglutaminase 2 enzymatic activity ameliorates the anti-angiogenic effects of coeliac disease autoantibodies

K. Kaukinen, I. Korponay-Szabó, M. Mäki, 2010, Scandinavian journal of gastroenterology.

RhoB is associated with the anti-angiogenic effects of celiac patient transglutaminase 2-targeted autoantibodies

K. Kaukinen, I. Korponay-Szabó, M. Mäki, 2011, Journal of Molecular Medicine.